Literature DB >> 31609141

Optimization of Meniscus Cell Transduction Using Lentivirus and Adeno-Associated Virus for Gene Editing and Tissue Engineering Applications.

Paolo Arrigoni1,2,3, Jacob C Ruprecht1,4, Dawn A D Chasse1, Katherine A Glass4, Benjamin Andress5, Farshid Guilak6,7, J Brice Weinberg8,9, Amy L McNulty1,5.   

Abstract

OBJECTIVES: The utilization of viral vectors to deliver genes of interest directly to meniscus cells and promote long-term modulation of gene expression may prove useful to enhance meniscus repair and regeneration. The objective of this study was to optimize and compare the potential of lentivirus (LV) and adeno-associated virus (AAV) to deliver transgenes to meniscus cells in both intact meniscus tissue and isolated primary cells in monolayer.
DESIGN: Porcine meniscus tissue explants and primary meniscus cells in monolayer were transduced with LV or self-complementary AAV2 (scAAV2) encoding green fluorescent protein (GFP). Following transduction, explants were enzymatically digested to isolate meniscus cells, and monolayer cells were trypsinized. Isolated cells were analyzed by flow cytometry to determine percent transduction.
RESULTS: LV and scAAV2 showed a high transduction efficiency in monolayer meniscus cells. scAAV2 was most effective at transducing cells within intact meniscus tissue but the efficiency was less than 20%. Outer zone meniscus cells were more readily transduced by both LV and scAAV2 than the inner zone cells. Higher virus titers and higher cell density resulted in improved transduction efficiency. Polybrene was necessary for the highest transduction efficiency with LV, but it reduced scAAV2 transduction.
CONCLUSIONS: Both LV and scAAV2 efficiently transduce primary meniscus cells but only scAAV2 can modestly transduce cells embedded in meniscus tissue. This work lays the foundation for viral gene transfer to be utilized to deliver bioactive transgenes or gene editing machinery, which can induce long-term and tunable expression of therapeutic proteins from tissue-engineered constructs for meniscus repair and regeneration.

Entities:  

Keywords:  CRISPR-Cas9; fibrocartilage; gene therapy; osteoarthritis; retrovirus

Mesh:

Year:  2019        PMID: 31609141      PMCID: PMC8804750          DOI: 10.1177/1947603519880321

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   3.117


  15 in total

1.  Formation of vascularized meniscal tissue by combining gene therapy with tissue engineering.

Authors:  Chisa Hidaka; Clemente Ibarra; Jo A Hannafin; Peter A Torzilli; Mannix Quitoriano; Shih-Shi Jen; Russell F Warren; Ronald G Crystal
Journal:  Tissue Eng       Date:  2002-02

2.  Overexpression of TGF-β via rAAV-Mediated Gene Transfer Promotes the Healing of Human Meniscal Lesions Ex Vivo on Explanted Menisci.

Authors:  Magali Cucchiarini; Katharina Schmidt; Janina Frisch; Dieter Kohn; Henning Madry
Journal:  Am J Sports Med       Date:  2015-02-02       Impact factor: 6.202

3.  Biomaterial-mediated delivery of degradative enzymes to improve meniscus integration and repair.

Authors:  Feini Qu; Jung-Ming G Lin; John L Esterhai; Matthew B Fisher; Robert L Mauck
Journal:  Acta Biomater       Date:  2013-01-29       Impact factor: 8.947

Review 4.  Advances in combining gene therapy with cell and tissue engineering-based approaches to enhance healing of the meniscus.

Authors:  M Cucchiarini; A L McNulty; R L Mauck; L A Setton; F Guilak; H Madry
Journal:  Osteoarthritis Cartilage       Date:  2016-04-05       Impact factor: 6.576

5.  Enhanced integrative repair of the porcine meniscus in vitro by inhibition of interleukin-1 or tumor necrosis factor alpha.

Authors:  Amy L McNulty; Franklin T Moutos; J Brice Weinberg; Farshid Guilak
Journal:  Arthritis Rheum       Date:  2007-09

6.  Genetically enhanced engineering of meniscus tissue using ex vivo delivery of transforming growth factor-beta 1 complementary deoxyribonucleic acid.

Authors:  Andre F Steinert; Glyn D Palmer; Ramille Capito; Jochen G Hofstaetter; Carmencita Pilapil; Steven C Ghivizzani; Myron Spector; Christopher H Evans
Journal:  Tissue Eng       Date:  2007-09

7.  Ex vivo serotype-specific transduction of equine joint tissue by self-complementary adeno-associated viral vectors.

Authors:  L R Goodrich; V W Choi; B A Duda Carbone; C W McIlwraith; R J Samulski
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

8.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

9.  Lentiviral-mediated correction of MPS VI cells and gene transfer to joint tissues.

Authors:  Sharon Byers; Miriam Rothe; Jelena Lalic; Rachel Koldej; Donald S Anson
Journal:  Mol Genet Metab       Date:  2009-02-27       Impact factor: 4.797

10.  Polybrene inhibits human mesenchymal stem cell proliferation during lentiviral transduction.

Authors:  Paul Lin; Diego Correa; Yuan Lin; Arnold I Caplan
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.